1Y Annualised Return
▲6.09%
3Y Annualised Return
▲16.19%
5Y Annualised Return
▲34.68%
Sakar Healthcare Stock Performance
|
|
|
Sakar Healthcare Company background
Founded in: 2004
Managing director: Sanjay S Shah.
Sakar Healthcare Limited was incorporated as a Private Limited Company under the name Sakar Healthcare Private Limited on 26th March 2004. Subsequently, the Company was converted into Public Limited Company on March 27, 2015 and the name of the Company was changed to Sakar Healthcare Limited. The Company is promoted by Sanjay Shah, Rita Shah and Aarsh Shah.The Company is engaged in manufacturing of Pharmaceutical products providing Liquid Orals, Cephalosporin Tablet, Capsule, Dry Powder Syrup, Dry Powder Injections, Liquid Injectables (SVP) in Ampoules and Vials Lyophilized Injections and Oral Solid Dossages. It manufactures and markets pharmaceutical formulations relating to analgesics, anti coagulants, anti malarial, anti spasmodic, antianemics, antibiotics, antiemetics, antihistamines, bronchodilators, corticosteroids, cough and cold preparations, multivitamins, etc.The Company operates as contract development and manufacturing organisation (CDMO), being the EU GMP approved CMO for leading multinational pharmaceutical companies.Their 4 manufacturing facilities located at Changodar, Ahmedabad, Gujarat. have been approved by various international regulatory authorities and certified by ISO 9001:2008 (BVQI), WHOGMP, CGMP National Drug Authority, and it has obtained certain drug specific registrations from the relevant authorities in countries such as Uganda, Kenya, Yemen, Ethiopia, Congo, Ghana, Zimbabwe, Namibia, Nigeria, Cote divoire.In 2005, the Company started commercial production for Plant 1 which was established for production of Liquid Orals in 2007, it started exporting its products overseas started commercial production for Plant 2 which was established for production of Beta Lactum Tablet and Capsules and Dry Syrup Blactum. / Sachet in 2008. Further, it started commercial production for Plant 3 which was established for production of Liquid Injectibles (SVP) Ampoules and Liquid Injectibles (SVP) Vials.In 2012, it started commercial production for Plant 4 which was established for production of Dry Powder Injection. In 2017, it started Lyophilised injection product commercialisation.In 2020, the Company received EU GMP certification for SVP unit manufacturing liquid and Lyophilised injections. In 2021, the Oncology Unit started operations in Bavla location. In 202223, the Company started commercialization with Oncology product post receiving WHO GMP certification.
Sakar Healthcare Financial Highlights
Sakar Healthcare reported a Q1 FY 2025-26
revenue of ₹52.74 crore,
up 14.3% YoY,
with net profit increased
50.0% to ₹4.67 crore. For the full year FY2025–2026, revenue
reached ₹178.9 crore and profit touched at
₹17.5 crore.
Sakar Healthcare Share Price Today
As of 18 Sep, 2025, Sakar Healthcare share price is ₹339.9. The stock opened at ₹338 and had closed at ₹339.8 the previous day. During today’s trading session, Sakar Healthcare share price moved between ₹332.15 and ₹346.00, with an average price for the day of ₹339.07. Over the last 52 weeks, the stock has recorded a low of ₹210.10 and a high of ₹380.80. In terms of performance, Sakar Healthcare share price has increased by 42.4% over the past six months and has increased by 6.09% over the last year.
Sakar Healthcare SIP Return Calculator
Over the past
1 year
3 years
5 years
Total Investment of ₹65,00,000
Would have become ₹67,02,765 (+3.12%)
Daily SIP of ₹25,000 would have become ₹67,02,765 in 1 year with a gain of ₹2,02,765 (+3.12%)
Sakar Healthcare Fundamental
Market Cap (in crs)
756.27
Face Value
10
Turnover (in lacs)
93.27
Key Metrics
Qtr Change %
61.78% Gain from 52W Low
6.6
Dividend yield 1yr %
0
Sakar Healthcare Key Financials
Loading chart...
Loading chart...
Loading chart...
Loading chart...
Sakar Healthcare Quarterly Revenue
| Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
52.74 Cr | 50.24 Cr | 43.42 Cr | 42.78 Cr | 41.15 Cr |
Sakar Healthcare Yearly Revenue
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|
178.9 Cr | 156.53 Cr | 138.03 Cr | 130.4 Cr | 95.91 Cr | 85 Cr |
Sakar Healthcare Quarterly Net Profit/Loss
| Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
4.67 Cr | 5.76 Cr | 4.53 Cr | 4.8 Cr | 2.41 Cr |
Sakar Healthcare Yearly Net Profit/Loss
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|
17.5 Cr | 11.67 Cr | 12.76 Cr | 15.18 Cr | 10.68 Cr | 9.62 Cr |
Sakar Healthcare Result Highlights
Result Summary
-
Sakar Healthcare Ltd reported a 21.2% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Jun (Q1 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 27.7%.
-
Its expenses for the quarter were up by 22.3% QoQ and 29.3% YoY.
-
The net profit increased 49.7% QoQ and increased 93.8% YoY.
-
The earnings per share (EPS) of Sakar Healthcare Ltd stood at 2.1 during Q1 FY 2025-26.
Data Source: BSE, Company announcements
The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.
Sakar Healthcare Technical Analysis
Moving Averages Analysis
Moving Averages Analysis
339.9
Current Price
5Day EMA
339.00
10Day EMA
337.50
12Day EMA
337.10
20Day EMA
336.20
26Day EMA
336.30
50Day EMA
335.30
100Day EMA
326.80
200Day EMA
317.40
5Day SMA
339.40
10Day SMA
336.90
20Day SMA
334.60
30Day SMA
332.60
50Day SMA
340.30
100Day SMA
330.10
150Day SMA
303.60
200Day SMA
302.60
Delivery & Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume |
|---|---|---|
Day Rs | 27441 Rs | 27441 Rs |
Week Rs | 14814 Rs | 14814 Rs |
Month Rs | 13462 Rs | 13462 Rs |
Resistance & Support
339.35
Pivot
Resistance
First Resistance
346.55
Second Resistance
353.20
Third Resistance
360.40
Support
First Support
332.70
Second support
325.50
Third Support
318.85
Relative Strength Index
53.44
Money Flow Index
67.44
MACD
0.78
MACD Signal
-0.44
Average True Range
12.91
Average Directional Index
12.64
Rate of Change (21)
5.15
Rate of Change (125)
43.95
Sakar Healthcare Peer comparison
| Index Name | Market Price | Market Cap | 52W Low | 52W High | Prev. Close | 1W Return | 1M Return | 6M Return | 1Y Return | 3Y Return | Dividend Yield | PE Ratio | Industry PE | PB Ratio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
365.00 | 638.05 | 293.53 | 500 | 361.90 | -0.53% | -14.21% | 16.21% | -1.03% | 122.82% | 0.00% | 20.10 | 41.12 | 2.12 | |
176.47 | 852.10 | 154.06 | 358 | 177.73 | -3.42% | 12.42% | 11.31% | -48.77% | 0.07% | 1.70% | 32.59 | 41.12 | 1.97 | |
- | 254.60 | - | - | - | - | - | - | - | - | - | - | - | - | |
1,353.20 | 836.28 | 957 | 2199 | 1,423.10 | -3.29% | -1.46% | 19.22% | -36.33% | -11.18% | 0.13% | 46.63 | 41.12 | 2.99 | |
558.90 | 717.44 | 500 | 950 | 565.20 | -3.31% | -0.42% | -19.87% | -36.55% | 123.59% | 0.00% | 32.76 | 41.12 | 4.94 | |
Anlon Healthcare Ltd. | - | 129.06 | - | - | - | - | - | - | - | - | - | - | - | - |
Sakar Healthcare Share Price FAQs
How has Sakar Healthcare shares performed in the past ?
Sakar Healthcare share price in the past 1-year return was 3.89. The Sakar Healthcare share hit a 1-year low of Rs. 210.1 and a 1-year high of Rs. 380.8.
What is the market cap of Sakar Healthcare ?
The market cap of Sakar Healthcare is Rs. 756.27 Cr. as of 17/9/2025.
What is the current P/E ratio of Sakar Healthcare ?
The PE ratios of Sakar Healthcare is 38.19 as of 17/9/2025.
What is the current PB ratio of Sakar Healthcare ?
The PB ratios of Sakar Healthcare is 2.57 as of 17/9/2025
How to buy Sakar Healthcare shares?
You can easily buy Sakar Healthcare shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
What is the 52-week high and low of Sakar Healthcare ?
The 52-week high and low of Sakar Healthcare share price is ₹380.8 and ₹210.1 as of 17/9/2025.
What is the EPS of Sakar Healthcare ?
The earnings per share (EPS) of Sakar Healthcare stood at 2.1 during Q1 FY 2025-26.
Please be aware that Sakar Healthcare stock prices are subject to continuous fluctuations due to various factors.
Invest in Sakar Healthcare